comparemela.com
Home
Live Updates
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in China : comparemela.com
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in China
/PRNewswire/ -- Photocure ASA (PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (688176.SH) has obtained approval to...
Related Keywords
Norway ,
Australia ,
Taiwan ,
United States ,
New Zealand ,
Hainan ,
China ,
Oslo ,
Chile ,
Canada ,
Chinese ,
American ,
Prnewswire Photocure ,
Erik Dahl ,
Dan Schneider ,
David Moskowitz ,
Cysview Hexvix ,
Hexvix Cysview ,
Hainan Provincial Medical Products Administration ,
National Medical Products Administration Center ,
Bladder Cancer Company ,
Chinese Urological Association Guideline ,
Asieris Pharmaceuticals ,
Corporate Communications Norway ,
Oslo Stock Exchange ,
American Cancer Society ,
Drug Evaluation ,
Hainan Province ,
Chinese Urological Association ,
Hainan Pilot ,
American Cancer ,
Blue Light Cystoscopy ,
Photocure ,
comparemela.com © 2020. All Rights Reserved.